XBIT 株価推移チャート
XBIT 財務
XBiotech Inc
$2.46
-1.6%
$-0.04
終値： May 08, 16:00:00 GMT-4
$2.46
0%
$0
アフターマーケット：May 08, 20:00:00 GMT-4
戻る
XBiotech Inc (XBIT) 財務
主要データ
前終値
$2.5
始値
$2.52
当日レンジ
$2.46 - $2.52
52週レンジ
$2.09 - $3.61
取引高
21.9K
平均取引高
39.4K
配当利回り
--
1株当たり利益(TTM)
-1.49
時価総額
$75.0M
XBITとは何ですか？
XBiotech, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutic antibodies. The company is headquartered in Austin, Texas and currently employs 85 full-time employees. The company went IPO on 2015-04-15. The firm's True Human monoclonal antibodies are derived from human donors that mount a natural human immune response. The firm is focused on therapies that block a potent substance, known as interleukin-1 alpha (IL-1a), that mediates a number of pathophysiological processes including tissue breakdown (i.e. synovium, cartilage, bone), paraneoplastic angiogenesis and tumor stroma remodeling, formation of blood clots, malaise, muscle wasting and general inflammation. The company has various candidate products, including Natrunix. The company has a clinical-stage therapeutic for methicillin resistant Staphylococcus aureus (MRSA), and several pre-clinical-stage therapeutics, including an oral delivery antibody therapeutic for colon infection by C. difficile.
